Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 2Lung Neoplasms 2Odontogenic Cysts 1Nose Neoplasms 1Neoplasms 1Melanoma 1Liver Neoplasms 1Kidney Neoplasms 1Esthesioneuroblastoma, Olfactory 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1Cancer Diagnosis 1

Interventions

Docetaxel 277Prednisone 237enzalutamide 177Leuprolide 172Radiotherapy 164Abiraterone Acetate 154Magnetic Resonance Spectroscopy 147bicalutamide 137Goserelin 134Androgen Antagonists 111Radiosurgery 101acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 100apalutamide 79abiraterone 77gallium 68 PSMA-11 74Specimen Handling 67darolutamide 58Gonadotropin-Releasing Hormone 58Radiation 56Triptorelin Pamoate 53cabazitaxel 50Zoledronic Acid 49pembrolizumab 48Radiotherapy, Intensity-Modulated 47Flutamide 47Brachytherapy 47luprolide acetate gel depot 46Standard of Care 45Carboplatin 44Estramustine 43

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Prostatic Neoplasms × Radionuclide Imaging × Clear all
NCT06003556 2026-06-03

P-GAP

University of Alberta

Phase 2 Recruiting
138 enrolled
Genitourinary

Prostatic Neoplasms

NCT05141760 2024-06-06

18F-PSMA PET and MRI in the Primary Staging of Prostate Cancer Patients

University of Alberta

Phase 2 Completed
150 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡